STATE-OF-THE-ART FACILITY FROM PRECLINICAL TO COMMERICAL STAGES FOR TRANSLATING VECTOR GENE-DELIVERY PLATFORMS INTO VACCINES AND ADVANCED THERAPIES

EXPERTISE MEETS EXPERIENCE

The building blocks for your success.

Unlocking the potential
of ground-breaking projects

ReiThera Srl is an Italian-based CDMO offering best-in-class process development and GMP manufacturing services for viral vectors. We provide the full suite of services for the clinical translation of genetic vaccines and medicinal products for advanced therapies.

We have extensive expertise in developing scalable processes for viral-vector manufacturing and a consolidated experience in GMP production of Adeno-Associated Vector (AAVx), Lentivirus, Adeno Viral vector (AdV), Modified Vaccinia Ankara and Herpes Simplex Vector.

The core manufacturing capacity is based in a state-of-the-art facility, which includes stirred-tank bioreactors at scales of 50L, 200L, 1000L, and 2000L, as well as fixed-bed bioreactors for cell growth in adherence. The GMP facility also comprises a filling suite and quality control laboratories.

Our headquarters, R&D laboratories, and GMP facilities are located in Rome, Italy.

Empowering technology and manufacturing of modern medicines

Our science

The growth of gene delivery technologies is at the core of a healthcare revolution – a step beyond one-size-fits-all approaches with the potential for individualized treatments. Over the past few decades, increased understanding of immunology and genomics has generated an unprecedented amount of biological information, which scientists are now beginning to translate into new life saving medicines.

ReiThera made significant improvements in viral vector engineering, from biological questions faced in early-stage research, to challenges of manufacturing and commercializing such therapies. Viral vector manufacturing portfolio currently includes human and primate adenoviruses, Adeno-Associated Viruses (AAV) and MVA. Our scientists are continuously working on groundbreaking projects with the purpose of empowering viral-vectored technology for next-generation immunotherapeutic and gene therapy products.

We believe that optimal engineering, process development and GMP manufacturing will place viral vector-based therapy at the forefront of modern medicine.

CDMO – Contract Development Manufacturing Organization

Our state-of-the-art and fully-equipped facilities can satisfy even the highest demand regarding the development, manufacture, and storage of viral vectors, drugs, and clinical samples.

Keep updated on ReiThera’s activities

Last news

Get in touch with our team. We will be in contact soon.

Please contact us for any inquiry

    Keep updated on ReiThera’s activities

    Last news